Effect of high-flow nasal cannula on thoraco-abdominal synchrony in adult critically ill patients

…, N Okuda, Y Tsunano, H Kohata, E Nakataki… - Respiratory …, 2014 - rc.rcjournal.com
BACKGROUND: High-flow nasal cannula (HFNC) creates positive oropharyngeal airway
pressure and improves oxygenation. It remains unclear, however, whether HFNC improves …

Professional burnout among physicians and nurses in Asian intensive care units: a multinational survey

KC See, MY Zhao, E Nakataki, K Chittawatanarat… - Intensive care …, 2018 - Springer
Purpose Professional burnout is a multidimensional syndrome comprising emotional
exhaustion, depersonalization, and diminished sense of personal accomplishment, and is …

Retreatment of lung adenocarcinoma patients with gefitinib who had experienced favorable results from their initial treatment with this selective epidermal growth …

S Yano, E Nakataki, S Ohtsuka, M Inayama… - Oncology …, 2005 - europepmc.org
Gefitinib is a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinases,
and shows favorable antitumor activity against chemorefractory non-small cell lung cancer (…

Humidification performance of two high-flow nasal cannula devices: a bench study

…, M Izawa, N Okuda, T Itagaki, E Nakataki… - Respiratory …, 2014 - rc.rcjournal.com
INTRODUCTION: Delivering heated and humidified medical gas at 20–60 L/min, high-flow
nasal cannula (HFNC) creates low levels of PEEP and ameliorates respiratory mechanics. It …

Effect of electrical muscle stimulation on upper and lower limb muscles in critically ill patients: a two-center randomized controlled trial

…, T Yamamoto, Y Ueno, E Nakataki… - Critical Care …, 2020 - journals.lww.com
Objectives: Electrical muscle stimulation is widely used to enhance lower limb mobilization.
Although upper limb muscle atrophy is common in critically ill patients, electrical muscle …

[HTML][HTML] Change in diaphragm and intercostal muscle thickness in mechanically ventilated patients: a prospective observational ultrasonography study

N Nakanishi, J Oto, Y Ueno, E Nakataki, T Itagaki… - Journal of Intensive …, 2019 - Springer
Background Diaphragm atrophy is observed in mechanically ventilated patients. However,
the atrophy is not investigated in other respiratory muscles. Therefore, we conducted a two-…

Urinary titin is a novel biomarker for muscle atrophy in nonsurgical critically ill patients: a two-center, prospective observational study

…, K Hara, T Takashima, E Nakataki… - Critical Care …, 2020 - journals.lww.com
Objectives: Although skeletal muscle atrophy is common in critically ill patients, biomarkers
associated with muscle atrophy have not been identified reliably. Titin is a spring-like protein …

A prospective clinical trial on prevention of catheter contamination using the hub protection cap for needleless injection device

J Oto, H Imanaka, M Konno, E Nakataki… - American journal of …, 2011 - Elsevier
BACKGROUND: Catheter hub contamination has been recognized as a source of catheter-related
bloodstream infections. We have investigated the efficacy of a protection cap for a …

Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES‐10 cells) highly expressing vascular endothelial growth factor and its …

E Nakataki, S Yano, Y Matsumori, H Goto… - Cancer …, 2006 - Wiley Online Library
Malignant pleural mesothelioma (MPM) is closely related to exposure to asbestos, and a
rapid increase in the number of MPM patients in Japan is estimated in the years 2010–2050. …

ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural …

Y Matsumori, S Yano, H Goto, E Nakataki… - Oncology …, 2006 - europepmc.org
ZD6474 is a novel, orally active inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2)
tyrosine kinase, with some additional activity against epidermal growth factor …